Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Oct. 31, 2017
Oct. 31, 2016
Oct. 31, 2017
Oct. 31, 2016
Revenues:        
Revenue $ 0 $ 0 $ 0 $ 0
Operating Expenses:        
Research and development costs 515,458 253,768 943,128 428,772
Compensation expense 575,513 491,472 1,156,947 906,478
Director fees 82,135 9,000 178,481 18,000
Legal and professional 132,430 56,760 327,539 234,765
General and administrative 508,762 163,195 896,618 417,577
Total operating expenses 1,814,298 974,195 3,502,713 2,005,592
Loss from operations (1,814,298) (974,195) (3,502,713) (2,005,592)
Other income (expense):        
Interest expense 0 (356) 0 (925)
Total other income (expense), net 0 (356) 0 (925)
Net loss $ (1,814,298) $ (974,551) $ (3,502,713) $ (2,006,517)
Basic and diluted loss per share $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average shares outstanding basic and diluted 973,167,811 848,910,100 949,373,602 818,540,900